Search | Page 17451 | DrugPrice

Registration

Search

Listing 349001 - 349020 out of 505060 entries

Country	ATC	Drug name	Drug form, strength, package	Price level	Price in €	Price in local currency	Therapeutic areas	Manufacturer / Importer
Norway	(L04AC05) ustekinumab	Stelara 45 mg	1 x 0.5 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 45 mg , Ferdigfylt sprøyte	Retail price with vat	$0-0	$0-0	Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative	Janssen-CilagInternationalN.V.
Norway	(L04AC05) ustekinumab	Stelara 45 mg	1 x 0.5 ml, Hetteglass, Injeksjonsvæske, oppløsning, 45 mg , Hetteglass	Retail price with vat	$0-0	$0-0	Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative	Janssen-CilagInternationalN.V.
Norway	(L04AC05) ustekinumab	Stelara 90 mg	1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 90 mg , Ferdigfylt penn	Retail price with vat	$0-0	$0-0	Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative	Janssen-CilagInternationalN.V.
Norway	(L04AC05) ustekinumab	Stelara 90 mg	1 x 1 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 90 mg , Ferdigfylt sprøyte	Retail price with vat	$0-0	$0-0	Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative	Janssen-CilagInternationalN.V.
Norway	(L04AC07) tocilizumab	RoActemra 20 mg/ml	1 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection	RocheRegistrationGmbH
Norway	(L04AC07) tocilizumab	RoActemra 20 mg/ml	1 x 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection	RocheRegistrationGmbH
Norway	(L04AC07) tocilizumab	RoActemra 20 mg/ml	1 x 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection	RocheRegistrationGmbH
Norway	(L04AC07) tocilizumab	Tyenne 20 mg/ml	1 x 10 ml, Hetteglass, Infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis	FreseniusKabiDeutschlandGmbH
Norway	(L04AC07) tocilizumab	Tyenne 20 mg/ml	1 x 4 ml, Hetteglass, Infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis	FreseniusKabiDeutschlandGmbH
Norway	(L04AC07) tocilizumab	RoActemra 20 mg/ml	4 x 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection	RocheRegistrationGmbH
Norway	(L04AC07) tocilizumab	RoActemra 20 mg/ml	4 x 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection	RocheRegistrationGmbH
Norway	(L04AC07) tocilizumab	RoActemra 20 mg/ml	4 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection	RocheRegistrationGmbH
Norway	(L04AC07) tocilizumab	RoActemra 162 mg	4 x 0.9 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 162 mg , Ferdigfylt penn	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection	RocheRegistrationGmbH
Norway	(L04AC07) tocilizumab	RoActemra 162 mg	4 x 0.9 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 162 mg , Ferdigfylt sprøyte av glass	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection	RocheRegistrationGmbH
Norway	(L04AC12) brodalumab	Kyntheum 210 mg	2 x 1.5 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 210 mg , Ferdigfylt sprøyte	Retail price with vat	$0-0	$0-0	Psoriasis	LEOPHARMAA/S(Danmark)
Norway	(L04AC13) ixecizumab	Taltz 80 mg	1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 80 mg , Ferdigfylt penn	Retail price with vat	$0-0	$0-0	Psoriasis	EliLillyandCompany(Ireland)Limited
Norway	(L04AC14) sarilumab	Kevzara 150 mg	2 x 1.14 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg , Ferdigfylt penn	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid	SanofiWinthropIndustrie
Norway	(L04AC14) sarilumab	Kevzara 200 mg	2 x 1.14 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 200 mg , Ferdigfylt penn	Retail price with vat	$0-0	$0-0	Arthritis, Rheumatoid	SanofiWinthropIndustrie
Norway	(L04AC16) guselkumab	Tremfya 100 mg	1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 100 mg , Ferdigfylt penn	Retail price with vat	$0-0	$0-0	Psoriasis	Janssen-CilagInternationalN.V.
Norway	(L04AC16) guselkumab	Tremfya 100 mg	1 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 100 mg , Ferdigfylt sprøyte av glass	Retail price with vat	$0-0	$0-0	Psoriasis	Janssen-CilagInternationalN.V.

Pages

Do you need information on drug prices for professional use with extended data and functionalities? Try Ex-Price:

For Pharma Companies For Wholesalers For Payers

Do you have any questions?
Did you find in the official sources a different price of a drug compared to DrugPrice? Contact us!